We tested the hypothesis that treatment of transient focal cerebral ischemia in rat with antibodies directed against adhesion molecules reduces apoptosis. Rats (n = 31) were subjected to 2 h of middle cerebral artery (MCA) occlusion induced by intraluminal insertion of a nylon monofilament into the internal carotid artery. Upon reperfusion, animals were treated with monoclonal antibodies directed against intercellular adhesion mole cule (ICAM)-I) (n = 8) or integrin CDIlb/CDI8 (n = to), or administered IgG 1 as a control (n = 13). At 48 h after ischemia, animals were killed and the brains analyzed for ischemic cell damage, using hematoxylin and eosin (HIE); apoptosis, using the terminal deoxynucleotidyl trans ferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) method; and inflammatory celis, using immu nohistochemistry with an anti-myeloperoxidase (MPO)
Summary:
We tested the hypothesis that treatment of transient focal cerebral ischemia in rat with antibodies directed against adhesion molecules reduces apoptosis. Rats (n = 31) were subjected to 2 h of middle cerebral artery (MCA) occlusion induced by intraluminal insertion of a nylon monofilament into the internal carotid artery. Upon reperfusion, animals were treated with monoclonal antibodies directed against intercellular adhesion mole cule (ICAM)-I) (n = 8) or integrin CDIlb/CDI8 (n = to), or administered IgG 1 as a control (n = 13). At 48 h after ischemia, animals were killed and the brains analyzed for ischemic cell damage, using hematoxylin and eosin (HIE); apoptosis, using the terminal deoxynucleotidyl trans ferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) method; and inflammatory celis, using immu nohistochemistry with an anti-myeloperoxidase (MPO) Apoptosis is present in rat brain after onset of middle cerebral artery (MCA) occlusion and may contribute to ischemic tissue damage (Linnick et aI., 1993; Charriaut-Marlangue et aI., 1995; Li et aI., 1995a-d) . Cells exhibiting apoptotic morphology undergo a process of cell death that fundamentally differs from that of necrosis. Apoptosis is orches trated by gene and/or protein expression, in con trast to necrosis in which the initiating and promot ing events are primarily associated with disruption antibody. Data revealed a significant reduction in the vol ume of infarction (p < 0.0 1) and a decline in the absolute (p < 0.00 1), and normalized (to the ischemic area, p < 0.05) numbers of apoptotic cells in both animals treated with anti-ICAM-l and anti-CDllb antibodies compared to control animals. The numbers of immunoreactive MPO cells were also reduced in the treatment groups compared to those in the control group (p < 0.05). These data sug gest that treatment with anti-adhesion molecule antibod ies selectively reduce apoptosis, and that a contributing factor to the beneficial effect of antibody treatment for reducing ischemic cell damage may be a reduction in numbers of apoptotic cells. Key Words: Apoptosis Adhesion moiecuies-ICAM-I-CDII b-Antibodies Stroke-Rat. of ionic and metabolic homeostasis (Kerr et aI., 1972; Wyllie et aI., 1980; Ellis et aI., 1991; Bursch et aI., 1992; Vaux 1993; Vaux et aI., 1994; Steller (1995) .
Antibodies against adhesion molecules (Clark et aI., 1991a,b; Bowes et aI., 1993; Chen et aI., 1994; Chopp et aI., 1994; Jiang et aI., 1994; Zhang et aI., 1994 Zhang et aI., , 1995 , as well as antibiotics (Bowes et aI., 1993) , and proteins (Moyle et aI., 1994; Jiang et aI., 1995) have been used to reduce inflammatory cell response and cell damage after experimental cere bral ischemia, inflammatory cells presumably pro mote ischemic cell damage by microvascular occlu sion, thereby prolonging or intensifying the isch emic event, and by cytotoxic means, in which neutrophils release free radicals and proteases (En gler et aI., 1983; Braide et aI., 1984; Harlan 1985; Hallenbeck et aI., 1986; Schmid-Schonbein and En gler, 1986; Schmid-Schonbein 1987; Granger 1988; Mullane et aI., 1988; Lucchesi et aI., 1989; Weiss 1989) . Although the volume of cerebral infarction is reduced after administration of agents designed to reduce neutrophil adherence to endothelium and subsequent migration into the ischemic tissue, in flammatory cells may exacerbate ischemic cell damage by other means, such as by inducing apop tosis.
In the present study, we tested the effects of ad ministration of two anti-adhesion molecule antibod ies, anti-.
CDllb and anti-intercellular adhesion mol ecule (ICAM)-I, on the numbers of apoptotic cells in rats that have been subjected to transient MCA occlusion. We selected these two antibodies be cause they both show efficacy in reducing ischemic cell damage in the rat even when administered hours after the onset of focal cerebral ischemia (Chopp et aI., 1994; Zhang RL et aI., 1995; Zhang ZG et aI., in press ). However, these antibodies dif fer in that the anti-CDllb acts against a 132 integrin molecule that is primarily expressed within the leu kocyte, while the anti-ICAM-l antibody acts against a glycoprotein that is primarily expressed on the surface of the endothelial cell. Although ICAM-\ and 132 integrins induce apoptosis in T cells (Damle et aI., 1993) , to our knowledge, there have been no studies on the role of postischemic inflam matory cells and adhesion molecules as mediators of apoptosis.
METHODS
Male Wistar rats (weighing 270-300 g, n = 31) were used in the experiments. Transient MCA occlusion was induced by advancing a 4-0 surgical nylon monofilament into the internal carotid artery (ICA) to block the origin of the MCA (Zea Longa et aI., 1989; Chen et aI., 1992) . Briefly, animals were anesthetized with 3.5% halothane, and anesthesia was maintained with 1.0% halothane in 70% N20 and 30% O2 (voVvol) using a face mask. Rectal temperature was maintained at 37°C throughout the sur gical procedure using a feedback-regulated water heating system. The right femoral artery and vein were cannu lated for measuring blood gases (pH, Po2, Pco2) before ischemia and for drug administration, respectively. A length of 18.5-19.0 mm 4-0 surgical nylon filament with its tip rounded by heating near a flame, was advanced from the external carotid artery into the lumen of the ICA until it blocked the origin of the MCA. At 2 h after MCA oc clusion, animals were reanesthetized with halothane and reperfusion was performed by withdrawal of the filament until the tip cleared the ICA lumen.
Animals were divided into three groups. Anti-ICAM-l group (n = 8) animals were subjected to MCA occlusion and an anti-rat ICAM-l antibody was infused (i. v.) over a 3-min interval at a dose of 1 mg/kg upon reperfusion and 0.5 mg/kg at 22 h of reperfusion. Anti-CDllb group (n = 10) animals were subjected to MCA occlusion and anti CDllb antibody was infused (i. v.) over a 3-min interval at a dose of 2 mg/kg upon reperfusion and 1.0 mg/kg at 22 h of reperfusion. Control group (n = 13) animals were sub jected to MCA occlusion and an isotype-matched control antibody (mouse IgG 1, Sigma Chemicals, St. Louis, MO, U.S.A.) was administered upon reperfusion and at 22 h of reperfusion, using the same volume dose as the experi mental groups. The treatment antibodies have endotoxin levels of < 1.0 eu/mg.
The numbers of apoptotic cells within ischemic rat brain subjected to 2 h of MCA occlusion are maximum at 48 h after onset of ischemia in rats (Li et aI., 1995a) . Although it is preferable to kill animals at times >48 h when infarct volumes are to be measured, the primary hypothesis to be tested was that antibodies against adhe sion molecules reduce numbers of apoptotic cells in isch emic tissue; therefore, 48 hour was selected as the most efficacious time for counting of apoptotic cells.
Antibody to rat ICAM-l, designated lA29, was devel oped according to details provided in a recent publication and was obtained from Drs. Anthony Manning and Donald Anderson at the Up john Company (Kalamazoo, MI, U.S.A.). The anti CDltb antibody (clone IB6c, F(ab'}z) was obtained from Repligen Corporation (Cambridge, MA, U.S.A.), and is a mouse anti-rat antibody (Mulligan et aI., 1992 (Mulligan et aI., , 1993 Zhang ZG et aI., in press ).
Animals were anesthetized (i.m.) with ketamine (44 mg! kg/body wt) and xylazine (13 mg/kg/body wt) at 46 h of reperfusion. Rats were transcardially perfused with hep arinized saline and 10% buffered formalin, and brains were removed. Each brain was cut into seven 2 mm-thick coronal blocks (A-G), using a rat brain matrix. Brain tis sue was processed and embedded, and 5 /Lm-thick paraf fin sections were cut from each block and stained with hematoxylin and eosin (H/E) for histopathological evalu ation. In addition, adjacent 5 /Lm-thick paraffin sections were obtained from block D and a molecular biological histochemical system (ApopTag kit, Oncor, Gaithers burg, MD, U.S.A.) for specific staining of DNA fragmen tation and apoptotic bodies, the terminal deoxynucleoti dyl (TdT)-mediated dUTP biotin nick end labeling (TUNEL) stain (Gavrieli et aI., 1992) , and immunohisto chemistry of myeloperoxidase (MPO) for neutrophil de tection (Daugherty et aI., 1994) were employed.
The area of infarction was measured using a Global Lab Image analysis program (Data Translation, Malboro, MA, U.S.A.). Each H/E section was evaluated at x2.5 mag nification. The area of infarction and the area of the ipsi lateral hemisphere (mm 2 ) were calculated by tracing the areas on the computer screen. To reduce errors associ ated with the processing of tissue for histological analy sis, the area of infarction in each section was presented as the percentage of the infarct to the ipsilateral hemispheric area; the infarct volume was also presented as the per centage of infarct to the ipsilateral hemisphere. Cells exhibiting DNA fragmentation were counted in both the ipsilateral and contralateral hemispheres using a light microscope (x 200-300 magnification). Cells contain ing apoptotic bodies are referred to as apoptotic cells (Gavrieli et aI., 1992; Wijsman et aI., 1993; Wood et aI., 1993; Li et aI., 1995a) . The TUNEL method is based on the specific binding of TdT to the 3'-OH ends of DNA and the ensuing synthesis of a polydeoxynucleotide polymer. Briefly, after deparaffinizing the brain sections, digesting the protein in specimens with proteinase K, then quench ing endogenous peroxidase activity with 2% H202 in phosphate-buffered saline (PBS), slides were placed in equilibration buffer and then in TdT enzyme. followed by stop/wash buffer. After two drops of anti-digoxigenin peroxidase was applied to the slides, peroxidase was de tected with diaminobenzidine. Negative controls were performed using distilled water to replace TdT Enzyme. The labeling targets of the TUNEL staining were the new 3'-OH DNA ends generated by DNA fragmentation; these were typically localized in morphologically identi fiable nuclei and apoptotic bodies. The direct immuno peroxidase detection of digoxigenin-labeled DNA in thin sections of fixed tissue allowed analysis of scattered cells exhibiting DNA fragmentation at anatomical locations af ter MCA occlusion. In contrast, normal nuclei, which had relatively insignificant numbers of DNA 3' -OH ends, did not stain with the TUNEL method. Cells exhibiting ne crotic morphologies contained, in some instances, stain able concentrations of DNA ends; however, staining in necrotic cells appeared more diffuse than in apoptotic cells. Coronal sections stained with the TUNEL method were also counterstained with hematoxylin.
Numbers of neutrophils within brain were counted us ing immunohistochemical staining for MPO (Bradley et aI., 1982; Daugherty et aI., 1994) . MPO is a marker for inflammatory cells, primarily neutrophils (Barone et aI., 199 1). Sections (5 !Lm thick) adjacent to those used for counting apoptotic cells were obtained and stained with a polyclonal rabbit anti-human MPO antibody (Dako no. A398, Copenhagen, Denmark). All immunoreactive cells were counted within the ipsilateral hemisphere using a light microscope (magnification x 132).
Welch's two-sample t-tests were used to compare the anti-ICAM-l and anti-CDllb groups to the vehicle group with respect to lesion area, ratio of lesion area/ipsilateral hemisphere area, number of apoptotic cells, and ratio of the number of apoptotic cells to the lesion area. A Bon ferroni-adjusted ex-level of 0.025 (0.05/2) was used to in terpret results of each test. P-values of �0.025 were con sidered to be statistically significant, while p-values of 0.025-0.05 were considered to be "marginally" signifi cant. All measurements were performed blindly (by J.P., N.J., R.L.Z., Y.L.). All data are presented as mean value + SD.
RESULTS
Blood gases were within normal ranges for all animals and did not differ between groups (Table 1) . Animals treated with anti-ICAM-l and anti-CDllb antibodies exhibited percent cerebral infarct vol umes of 18.0 ± 11.2 (n = 8) and 24.3 ± 11.0 (n = 10), respectively, that were significantly smaller (p = 0.01) than the percent cerebral infarct volumes obtained in control animals (36.5 ± 7.7; n = 13). These data are consistent with those of our previous reports (Chen et aI., 1994; Jiang et aI., 1994; Zhang et aI., 1994) . Figure 1 shows a representative coronal section of striatal tissue from a control animal in which ap optotic and inflammatory cells are readily apparent within the ischemic region. As we have previously reported in control ischemic animals (Li et aI., 1995 a-c) , the apoptotic cells are primarily concentrated along the inner boundary of the zone of infarction.
The difference in the mean number of apoptotic cells was found to be significantly different between vehicle (186.3 ± 43.4; n = 13) and anti-ICAM-l (54.8 ± 57.0; n = 8) (p < 0.001), and vehicle and anti-CD lIb (79.3 ± 57.1; n = 10) (p < 0.001). For the normalized numbers of apoptotic cells, the ve hicle group (7.6 ± 2.6; n = 13) was found to be significantly different from the anti-ICAM-l (4.2 ± 3.2; n = 8) (p = 0.023), and the vehicle group was marginally significantly different from the anti CDlIb (4.9 ± 3.1; n = 10) treatment group (p = 0.040).
The number and ischemic area normalized num bers of MPO immunoreactive cells were signifi cantly (p < 0.01) reduced within the treated groups compared to the control group: control group (596 ± 331; 23.6 ± 11.6 mm-2; n = 5); anti-ICAM-l group (166 ± 144; 13.8 ± 8.3 mm-2; n = 6); and anti-CDllb group (170 ± 142; 16.1 ± 10.5 mm-5 ; n = 5). No difference was detected in the absolute and normalized numbers of MPO immunoreactive cells between the anti-ICAM-1 and anti-CDllb groups. Numbers of immunoreactive MPO and ap optotic cells within adjacent sections of tissue were highly correlated (r = 0.78; p < 0.001). Figure 2 illustrates the relative distribution of apoptotic and immunoreactive MPO cells within a coronal sec tion. Immunoreactive MPO cells exhibited a similar spatial pattern of distribution as the apoptotic cells.
DISCUSSION
Our data indicate that administration of antibod ies designed to reduce leukocyte adhesion and sub sequent migration into ischemic tissu� als� r�d . uces the numbers of apoptotic cells. There IS a sIgmficant attenuation of apoptotic cells (absolute and normal ized numbers) after treatment designed to reduce postischemic inflammatory response. Th�s, t . he therapeutic benefit of administration of antibodIes against adhesion molecules not only is associated with improvement of cerebral blood flow and r�du� tion of cytotoxicity but also includes a reductIOn In the number of cells undergoing apoptosis.
There are several possible explanations for the reduction of apoptotic cells after treatment with anti-adhesion molecule antibodies. Reduction of ap optosis can be attributed to a reduction in numbers of inflammatory cells and/or to a direct effect of the antibodies on parenchymal cells . Inflammatory cells can induce apoptosis (Squier et aI., 1995) . Cy totoxic T lymphocytes undergo apoptosis and in duce apoptosis in target cells (Duke et al . , 1983; Ucker, 1987; Sellins and Cohen 1991; Nagata and Golstein, 1995) . Although neutrophils undergo ap optosis (Squier et aI., 1995) , to date, there ar� �o reports that neutrophils directly induce apoptosiS In target cells. However, it is possible that the reduc tion in numbers of neutrophils within ischemic tis sue indirectly causes reduction of apoptosis. This hypothesis is consistent with the robust correlation of immunoreactive MPO and apoptotic cells as well as the similar spatial distribution of immunoreactive MPO and apoptotic cells. Neutrophils are a potent source of oxygen-free radicals, and free radicals in duce apoptosis (Hockenbery et aI., 1991 (Hockenbery et aI., , 1993 . Ad herent neutrophils can release oxidizing radicals into the neural cell cytoplasm. Proteases, likewise, induce apoptosis (Sarin et aI., 1993; Miura et aI., 1994; Thompson, 1995) , and leukocytes are a pro fuse source of proteases (Henson and Johnston, 1987; Weiss, 1989; Hansen, 1995) . Expression of matrix-degrading proteases in normal tissues causes apoptosis (Talhouk et aI., 1992) . Interleukin 1 . � converting enzyme (ICE) is a protease that facIh tates apoptosis in mammalian cell lines (Los et aI., 1995) , and inflammatory cells express proteases, such as granzyme �, with similar apoptotic activity (Sleath et ai., 1990; Howard et ai., 1991; Odake et aI., 1991; Shi et aI., 1992; Caputo et aI., 1994; Heu sel et ai., 1994) .
Reduction of apoptotic cells compared to vehicle treated animals was more pronounced with anti ICAM-l antibody treatment (p = 0.023) than with anti-CDllb antibody treatment (p = 0.040). How ever, the number of neutrophils within the ischemic tissue was nearly identical for the anti-ICAM-l and anti-CDllb-treated groups; if apoptosis is caused by a direct attack of neutrophils on the parenchymal cells, then we expect the numbers of apoptotic cells to closely reflect the numbers of neutrophils within the tissue. It is, therefore, unclear why blocking the ICAM-l sites shows a trend (although not statisti cally significant) towards being more effective in reducing apoptosis than blocking the CDllb sites. A possible explanation for the more potent a�ti ICAM-l reduction of apoptosis is that cell adheSIOn molecules (CAMs) directly affect neurons. During development of the nervous system, CAMs pro mote neuronal migration and axonal growth; yet, at other times, CAMs inhibit these events by main taining stable adhesion between cells (Doherty and Walsh, 1994) . Cytokines released in the course of inflammation induce expression of ICAM-l on neu rons, allowing them to be targeted by neutrophils (Birdsall, 1991) . Adherence of neutrophils to cyto kine-stimulated neural cells is mediated primarily by ICAM-l and lymphocyte function antigen-I (LFA-l) interactions, and 70-90% of the binding can be blocked by monoclonal antibodies to either ligand (Birdsall, 1991) . A direct role for adhesion molecule mediated-apoptosis was recently demon strated in which T-cell receptor-directed engage ment of integrins by their ligands ICAM-l or VCAM-l induced apoptosis of T cells (Damle et al.,. 1993) .
Although the mechanism by which the anti ICAM-l antibody inhibits apoptosis is not known, it may be related to a coupling of ICAM-l, IL-II3, and ICE. The mammalian gene, ICE, encodes a cys teine protease involved in the processing of IL-II3. ICE is required for the conversion of pro IL-113 into active IL-I�. ICE induces apoptosis and activates IL-l�, which, in turn, induces ICAM-I (Springer, 1994) . Conversely, whether blocking ICAM-I inhib its IL-l � and ICE, and, subsequently, reduces ap optosis is not known. An additional pathway relat ing adhesion molecules and apoptosis is related to the observation that tumor suppressor genes en code cell adhesion molecules (Hedrick et aI., 1993) . Tumor suppressor genes, e.g. p53, also induce ap optosis (Clarke et aI., 1993) . Thus, apoptosis may be facilitated by adhesion molecules, and, there fore, blocking adhesion molecules may reduce ap optosis, as demonstrated in the present study.
We have employed an immunohistochemical method using an anti-MPO antibody to measure in flammatory cells within the ischemic brain. This method has recently been applied to studies of hu man atherosclerotic lesions (Daugherty et al., 1994) , and we adapted this method to the study of brain. MPO is a gold standard measurement for the presence of neutrophils (Barone et aI., 1991) . Al though monocytes also possess MPO activity, MPO in monocytes accounts for < 1 % of the MPO recov ered from inflammatory skin lesions (Bradley et aI., 1982) . We cannot exclude the possibility that other cells, such as monocytes and macrophages, may be included in the total MPO positive cell count .
The cellular target for the anti-adhesion molecule antibodies is not restricted to neutrophils, but may also include other exogenous inflammatory cells, such as monocytes and T lymphocytes. The anti bodies employed in the present study are effective on different leukocytes. The CD 11 b receptor is most prominently expressed on neutrophils and monocytes (Kishimoto et aI., 1989) . In contrast, the ICAM-l is a ligand for multiple 132 integrins, includ ing those such as LF A-I, that are expressed on lym phocytes (Rothlein et aI., 1986; Simmons et aI., 1988; Staunton et aI., 1988) . ICAM-l is also ex pressed in primary cultures of rat astrocytes (Shri kant et aI., 1994) . Although the focus of our study was apoptosis and MPO immunoreactive cells and although we did not measure the temporal profile of lymphocytes in ischemic tissue in the present study, T lymphocytes were present. Figure 3 shows a T lymphocyte within the ischemic tissue at 48 h after onset of reperfusion. It is, thus, possible, and fur ther study is required to demonstrate, that the abil ity of the anti-adhesion molecule antibodies to re duce apoptosis may be related to the effect of anti bodies, particularly ICAM-I, which is a ligand for LF A-I, on T lymphocytes or other inflammatory cells.
In summary, we have demonstrated that antibod ies directed against CDl1b and ICAM-I adhesion molecules suppress apoptosis in ischemic brain. This observation raises the intriguing possibility that inflammatory cells and/or adhesion molecules and receptors promote apoptosis, and that antibod ies against adhesion molecules suppress apoptosis in ischemic brain .
